Figure 5.
a Kaplan-Meier curves depicting the disease-free (DFS, left panel) and overall survival (OS, right panel) of younger (aged <60 years) adult patients with acute myeloid leukemia classified into proposed Favorable-risk (blue line), Intermediate-risk (black) and Adverse-risk (red) 2017 European LeukemiaNet (ELN) groups after the proposed refinement of the ELN classification. b DFS (left graph) and OS (right graph) of younger patients classified into the original ELN genetic-risk groups.